SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2,513 Cr | ₹-7,906 Cr | ₹-6,710 Cr | ₹2,376 Cr | ₹-5,193 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-2,513 Cr |
| Mar2025 | ₹-7,906 Cr |
| Mar2024 | ₹-6,710 Cr |
| Mar2023 | ₹2,376 Cr |
| Mar2022 | ₹-5,193 Cr |
How is Cash Flow from Financing Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2,513 Cr | Negative | |
| Mar2025 | ₹-7,906 Cr | Negative | |
| Mar2024 | ₹-6,710 Cr | Negative | |
| Mar2023 | ₹2,376 Cr | Positive | |
| Mar2022 | ₹-5,193 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,284.3 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
| MANKIND PHARMA | ₹109,622.0 Cr | 3% | 13.9% | 17.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -1.8% |
7.6% |
11.2% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses